Abstract
Oral squamous cell carcinoma (OSCC) is one of the most common cancers in the world. In OSCC, CD133 promotes tumor invasion and metastasis by inducing the epithelial-to-mesenchymal transition (EMT). A small subset of cancer cells known as cancer stem cells (CSCs) are thought to give rise to differentiated tumor cells and to predict tumor recurrence and metastases, i.e., CSCs may be metastatic precursors. In this study, we show that ectopic overexpression of CD133 in OSCC cell lines KB, YD9, and YD10B cells significantly promotes the EMT and acquisition of stemness properties. CSC properties were analyzed by colony-formation assay and measurement of OCT4, SOX2, and NANOG expression, and the EMT was monitored by cell migration, a cell invasion assay, and analysis of E-cadherin, N-cadherin, and vimentin expression. CD133 overexpression led to formation of irregular spheroid colonies consistent with a stem cell phenotype and increased the expression of OCT4, SOX2, NANOG, N-cadherin, and vimentin. Taken together, these findings show that elevated levels of CD133 lead to OSCC invasiveness and metastasis, associated with the upregulation of EMT and stemness markers.
Similar content being viewed by others
References
Haddad RI, Shin DM (2008) Recent advances in head and neck cancer. N Engl J Med 359(11):1143–1154
Jemal A et al (2008) Cancer statistics. CA Cancer J Clin 58(2):71–96
Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4(6):448–456
DiTroia JF (1972) Nodal metastases and prognosis in carcinoma of the oral cavity. Otolaryngol Clin N Am 5(2):333–342
Roepman P et al (2005) An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37(2):182–186
Noguti J et al (2012) Metastasis from oral cancer: an overview. Cancer Gen Proteomics 9(5):329–335
Hirshberg A et al (2008) Metastatic tumours to the oral cavity—pathogenesis and analysis of 673 cases. Oral Oncol 44(8):743–752
Ho CM et al (1992) Occult lymph node metastasis in small oral tongue cancers. Head Neck 14(5):359–363
Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10):755–768
Tirino V et al (2008) Detection and characterization of CD133 + cancer stem cells in human solid tumours. PloS One 3(10):e3469
Liu S et al (2015) G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma. Oncotarget 6(9):6887–6901
Angelastro JM, Lame MW (2010) Overexpression of CD133 promotes drug resistance in C6 glioma cells. Mol Cancer Res MCR 8(8):1105–1115
Zhang Q et al (2010) A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett 289(2):151–160
Corbeil D et al (2000) The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 275(8):5512–5520
Hilbe W et al (2004) CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 57(9):965–969
Hemmati HD et al (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100(25):15178–15183
Chu P et al (2009) Characterization of a subpopulation of colon cancer cells with stem cell-like properties. Int J Cancer 124(6):1312–1321
Chiou SH et al (2008) Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14(13):4085–4095
Carvalho AL et al (2005) Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114(5):806–816
Yang CC et al (2013) Membrane type 1 matrix metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells. BMC Cancer 13:171
Chen C et al (2011) Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PloS One 6(1):e16466
Micalizzi DS, Farabaugh SM, Ford HL (2010) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplas 15(2):117–134
Xu MH et al (2014) EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells. PloS One 9(2):e87893
Bernards R, Weinberg RA (2002) A progression puzzle. Nature 418:823
Kang HJ, Jang YJ (2012) Selective apoptotic effect of Zelkova serrata twig extract on mouth epidermoid carcinoma through p53 activation. Int J Or Sci 4(2):78–84
Lee EJ et al (2005) Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells. Exp Mol Med 37(5):379–390
Pang LY et al (2012) Identification of tumour initiating cells in feline head and neck squamous cell carcinoma and evidence for gefitinib induced epithelial to mesenchymal transition. Vet J 193(1):46–52
Zhou BB et al (2009) Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 8(10):806–823
Uchida N et al (2000) Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 97(26):14720–14725
Iannolo G et al (2008) Apoptosis in normal and cancer stem cells. Crit Rev Oncol Hematol 66(1):42–51
Mizrak D, Brittan M, Alison M (2008) CD133: molecule of the moment. J Pathol 214(1):3–9
Bourguignon LY et al (2012) Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem 287(39):32800–32824
Gangopadhyay S et al (2013) Breast cancer stem cells: a novel therapeutic target. Clin Breast Cancer 13(1):7–15
Mani SA et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704–715
Acknowledgments
This study was supported by research funds from Chosun University (2014). The authors declare that they have no conflicts of interest.
Author contributions
All authors have read and approved the final submitted manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
YeonHee Moon and Donghwi Kim have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Moon, Y., Kim, D., Sohn, H. et al. Effect of CD133 overexpression on the epithelial-to-mesenchymal transition in oral cancer cell lines. Clin Exp Metastasis 33, 487–496 (2016). https://doi.org/10.1007/s10585-016-9793-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-016-9793-y